title: [Severe sicca syndrome associated with primary biliary cirrhosis. Value of an immunosuppressive treatment].
authors.forename: H
authors.initials: H
authors.lastname: Rifflet
authors.forename: P
authors.initials: P
authors.lastname: Calés
authors.forename: F
authors.initials: F
authors.lastname: Oberti
authors.forename: I
authors.initials: I
authors.lastname: Fouchard
authors.forename: M C
authors.initials: MC
authors.lastname: Rousselet
authors.forename: J
authors.initials: J
authors.lastname: Cottereau
authors.forename: Y
authors.initials: Y
authors.lastname: Deugnier
authors.forename: J
authors.initials: J
authors.lastname: Dubin
authors.forename: C
authors.initials: C
authors.lastname: Masson
mesh_terms: D001379:Azathioprine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008105:Liver Cirrhosis, Biliary / Q000150:complications*; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use*; D012859:Sjogren's Syndrome / Q000188:drug therapy / Q000209:etiology*
chemical_list: D007166:Immunosuppressive Agents; D001379:Azathioprine; D011241:Prednisone
vernacular_title: Syndrome sec sévère associé à une cirrhose biliaire primitive. Intérêt d'un traitement immunosuppresseur.